Acorda Therapeutics Strikes Creditor Deal On Ch. 11 Loan

By Rick Archer · May 3, 2024, 12:53 PM EDT

A New York judge on Friday gave final approval to Acorda Therapeutics' $60 million Chapter 11 financing package after hearing the drug developer and the lenders had resolved objections lodged by...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Acorda Therapeutics, Inc.

Case Number

Court

New York Southern

Nature of Suit

Date Filed

April 01, 2024

Recent Articles By Rick

November 01, 2024
Ex-Parler Owner Has $6.3M Buyer In Ch. 11
November 01, 2024
Big Lots Says $760M Bid Wins In Ch. 11 Auction
October 31, 2024
Judge Upholds Sanctions Against Ex-Stimwave CEO
October 30, 2024
Conn's Seeks Hearing Next Week On Ch. 11 Asset Sale
October 30, 2024
Ex-LNG Contractor Not Entitled To Insurance Proceeds
October 29, 2024
Talc Miners Say They've Worked Out Kinks In Ch. 11 Plans
October 28, 2024
Judge Hopes To Avoid Vote Issue Repeat In Talc Ch. 11 Plan
October 25, 2024
US Trustee Opposes NJ Building's Receiver Stipulation
October 25, 2024
Big Lots Inc. Gets OK For Oct. 30 Ch. 11 Asset Auction
October 24, 2024
DOJ Says Bankrupt Wound Care Group Under Investigation